Extension Study of Maintenance Treatment With Subcutaneous Immunoglobulin (IgPro20) for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

PHASE3CompletedINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

July 30, 2014

Primary Completion Date

July 10, 2017

Study Completion Date

July 10, 2017

Conditions
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
Interventions
BIOLOGICAL

IgPro20

Trial Locations (33)

1105

Site Reference 5280001, Amsterdam

3065

Site Reference 0360011, Fitzroy

4102

Site Reference 0360017, Woolloongabba

10021

Site Reference 8400169, New York

10117

Site Reference 2760069, Berlin

12200

Site Reference 2760072, Berlin

14471

Site Reference 2760047, Potsdam

20133

Site Reference 3800031, Milan

28210

Site Reference 8400182, Charlotte

30625

Site Reference 2760054, Hanover

44791

Site Reference 2760049, Bochum

45117

Site Reference 2760052, Essen

45147

Site Reference 2760094, Essen

50003

Site Reference 2030009, Hradec Králové

50005

Site Reference 2030002, Hradec Králové

66160

Site Reference 8400166, Kansas City

90033

Site Reference 8400167, Los Angeles

97080

Site Reference 2760039, Würzburg

35294-0017

Site Reference 8400181, Birmingham

M5G 2C4

Site Reference 1240009, Toronto

J4V2J2

Site Reference 1240007, Greenfield Park

06002

Site Reference 2500022, Nice

DE04103

Site Reference 2760055, Leipzig

359-8513

Site Reference 3920037, Tokorozawa

755-8505

Site Reference 3920035, Ube

260-8677

Site Reference 3920038, Chiba

228-8555

Site Reference 3920061, Kanagawa

466-8560

Site Reference 3920040, Nagoya

113-8431

Site Reference 3920065, Tokyo

08035

Site Reference 7240011, Barcelona

08907

Site Reference 7240010, Barcelona

WC1N 3BG

Site Reference 8260019, London

M6 8HD

Site Reference 8260032, Salford

Sponsors

Lead Sponsor

All Listed Sponsors
lead

CSL Behring

INDUSTRY